Recent Headlines
Careington® CFO Melissa Baumann Honored as a Dallas Business Journal 2021 CFO of the Year Award Winner
Careington International Corporation is excited to announce Melissa Baumann has been honored as a CFO of the Year Award winner by the Dallas Business Journal. This is the Dallas Business Journal’s 13th annual CFO of the Year Awards which honors distinguished North Texas CFOs who demonstrate... - November 18, 2021 - Careington
PharmStars Announces Showcase Event for Inaugural Class
PharmStars, a pharma-focused accelerator for digital health startups, announces the start of its 2021 Showcase Event. At the Showcase Event, the 12 startups in the accelerator’s current cohort will pitch their digital health solutions to PharmStars’ pharma members. The startups and pharma members will also have the opportunity to meet privately to discuss potential partnership opportunities. - November 17, 2021 - PharmStars
Mirror Biologics Announces Issuance of US Patent Covering Next Generation Therapeutic Vaccine Technology for Treatment of Cancer and Infectious Disease
Mirror Biologics, Inc., a private clinical stage biopharmaceutical company, today announces the issuance of US Patent No. 11,160,852, “Method of Vaccinating Using Allogeneic Cells,” covering methods for creating a next generation of therapeutic vaccines against cancers and infectious... - November 17, 2021 - Mirror Biologics, Inc.
South-Tek Systems Appoints Jens Bolleyer as CEO
South-Tek Systems announces Jens Bolleyer was appointed as the company’s CEO effective August 30, 2021. An experienced business leader, Mr. Bolleyer steps into the CEO role at South-Tek with significant experience in manufacturing businesses serving commercial & industrial plumbing and... - November 16, 2021 - South Tek Systems
Careington® Works with Great Speech to Add Virtual Speech Therapy Services to Its Telehealth Offerings Nationwide
Careington International Corporation, a leader in the non-insured health care benefits space, is pleased to begin working with Great Speech Inc., a pioneer in the virtual speech therapy space, adding virtual speech therapy to Careington’s ever-expanding telehealth offerings. This relationship... - November 11, 2021 - Careington
Genetically Steady and Cost-Effective Gene Knockout Stable Cell Lines Products at Creative Biogene
Creative Biogene creatively develops a series of genetically steady and cost-effective gene knockout stable cell lines products for domestic and overseas clients. - November 06, 2021 - Creative Biogene
Eyecheck Announces FDA IND Clearance of STRI Formula, the First-Ever Food-Based, Combination Product in the STRI Phase 2 Clinical Trial for COVID-19 Symptoms
Eyecheck intends to initiate the Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial to evaluate STRI Formula in non-hospitalized adults with COVID-19. This trial is expected to begin in November 2021. - November 04, 2021 - Eyecheck, Inc.
Noble Paws CBD Joins Forces with Leading Pet Diabetes Brand
The pet CBD brand with an ethos, Noble Paws, donates a bottle of their healing CBD to a shelter every time one is purchased. Noble Paws has joined forces with rising star pet diabetes brand, PetTest, to reach as many pets as possible and “hemp” spread the word. - November 04, 2021 - Noble Paws
PharmStars Welcomes Sumitovant Biopharma as Its Newest Member
PharmStars, the only pharma-focused, member-based accelerator for digital health startups, is pleased to announce that Sumitovant Biopharma has become its newest pharma member, joining existing members including Boehringer Ingelheim, Eli Lilly and Company, and Novo Nordisk. PharmStars focuses on bridging the "pharma-startup gap." PharmStars provides startups with education and mentoring to help them engage with pharma as clients and partners. - November 03, 2021 - PharmStars
Creative Biogene Offers One-Stop Customized CRISPR-Based Microbe Genome Editing Service
CRISPR Platform is a mature system developed by Creative Biogene. Services like microbe’s gene knockout and gene knock-in central to the gene-editing area can be precisely performed based on the CRISPR platform. As a popular and useful tool in microbe genome editing, the CRISPR platform always presents excellent performance and serves quality-guaranteed results in a wide range of projects. - November 03, 2021 - Creative Biogene
Families of World War II Veterans Holds 2021 Fundraising Golf Tournament
Families of World War II Veterans will hold its annual golf tournament and fundraising event on Monday, October 25, 2021 at the award-winning Trinity Forest Golf Club in Dallas, Texas, the former home of the renowned AT&T Byron Nelson tournament. This year's tournament is presented by MetLife... - October 23, 2021 - Careington
ASHP Case Study on Drugs in Short Supply Highlights MedShorts Online Marketplace
The American Society of Health-System Pharmacists (ASHP) published a case study citing financial and sourcing successes for health system pharmacies utilizing the MedShorts marketplace for direct access to drugs. The data-driven marketplace consumes and analyzes data from ASHP Drug Shortages to match pharmacy needs and alleviate shortage occurrences. Read the case study: https://www.ashp.org/products-and-services/database-licensing-and-integration/ashp-drug-shortages/medshorts-case-study - October 21, 2021 - MedShorts LLC
Swiss Start-Up HealthyCheck Transforms the Way People Monitor Their Health Directly from Home
HealthyCheck today announces the launch of its new platform to transform the way people monitor their health. HealthyCheck is a start-up that focuses on providing many laboratory tests to the user directly from home. Users enjoy an easy and convenient way to test their health and monitor long term... - October 20, 2021 - HealthyCheck
Burn Boot Camp Robinson, PA Participates in Third Annual National "Be Their Muscle" Event
National Fitness Franchise, Burn Boot Camp, Holds Nationwide Camps on October 30 Benefitting Muscular Dystrophy Association (mda.org) as Company Closes in on $1 Million Fundraising Goal. - October 18, 2021 - Burn Boot Camp Robinson, PA
Pipelinepharma Closes €1.3M Seed Round to Shift Pharmaceutical Dealmaking Online
The European B2B pharmaceutical marketplace closed a venture seed round led by Practica Capital. Iron Wolf Capital, Pandos and a group of angel investors also participated in the funding round. - October 09, 2021 - Pipelinepharma
Omni-HC Selected to Participate in “Audience Amplification” Workshop at Prestigious Global Medical Affairs Meeting
Omni Healthcare Communications has been selected by the Medical Affairs Professional Society to convene a workshop on scientific communication amplification at the MAPS 2022 Global Annual Meeting. - October 02, 2021 - Sunny Ayr Holdings
Careington CIO, Rashmi Jain, to be a Panelist at the Women in Tech Summit
Careington International Corporation proudly announces Chief Information Officer Rashmi Jain will speak at the Women in Tech Summit. This event will take place during InnoTech Dallas on Tuesday, September 28 at the Irving Convention Center. The “Lessons from the Leaders” panel... - September 30, 2021 - Careington
Careington Announces Launch of QuoteSavant, a New Insurance Comparison Service
Careington International Corporation is excited to announce the launch of QuoteSavant, a customer-first insurance comparison service, and the newest addition to its affiliate company Careington Benefit Solutions, a nationally licensed Third Party Administrator and agency. - September 22, 2021 - Careington
Cayman Chemical Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration
The National Institute of Dental and Craniofacial Research has awarded Cayman Chemical with a $1,700,500 grant to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage... - September 19, 2021 - Cayman Chemical Company
AdvantaPure(R) Announces Fall Trade Show Appearances - Includes Events in the Northeast U.S.
AdvantaPure, the high purity division of NewAge Industries, will exhibit its silicone and TPE tubing and molded assemblies at the ISPE Boston Show, BioProcess International 2021, and Interphex, all taking place in September and October. AdvantaPure will also highlight its recent clean room expansion and its in-process building renovation at the events. The company is increasing its tubing manufacturing capacity to help meet demand for its Single-Use products. - September 16, 2021 - AdvantaPure
MEDraysintell Publishes the 8th Edition of Its Nuclear Medicine Report & Directory
A set of three volumes (3,100 pages) with a description of 870 products, together with a comprehensive profile of 340 companies active around the world in the radiopharmaceutical industry. - September 16, 2021 - MEDraysintell
Synformulas Presents the Scientifically Researched Potential of Its Products for the First Time at Vitafoods Europe
Common diseases such as gastrointestinal conditions and allergies are the focus of the company’s research and product development; More value is being added for further licensing and distribution partners through strong scientific research results; SYNformulas is seeking for additional distribution partners to expand its internationalization activities with its patented active complexes. - September 13, 2021 - SYNformulas
Mirror Biologics, Inc. Announces Initial Clearance for Phase II/III Clinical Trial (ALIVE) in Advanced Liver Cancer
Mirror Biologics, Inc, (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ vaccine immunotherapy for cancer and infectious diseases where... - September 10, 2021 - Mirror Biologics, Inc.
Aelius LED Office Expansion Improves Efficiency for Cultivators Worldwide
Canadian LED Grow Light Experts Move Into New Facility - September 07, 2021 - AeliusLED
Defined Bioscience Licenses FGF2-STAB (G3) for Use in Stem Cell Media
Defined recently concluded a licensing agreement with Czech Republic-based Enantis for global use of Enantis’ patented FGF2-STAB® technology both alone and in stem cell media formulations. FGF2-STAB®, originally coined FGF2-G3, was developed by Enantis and Masaryk University, using... - August 30, 2021 - Defined Bioscience Inc.
Podcast on Vitiligo with Recouleur® Vitiligo Vitamin Creator Audrey VanStockum
The podcast entitled “The Journey with Vitiligo with Audrey VanStockum,” will air August 31, 2021 at 11:00 a.m. CST and can be heard live as well as recorded after the show on Blog Talk Radio. VanStockum will discuss treatments she tried, and how she created Recouleur. - August 25, 2021 - Supernatural Health, Inc.
Omni Healthcare Communications & Res Consortium Form Alliance to Expand Medical Affairs Capabilities
Omni Healthcare Communications (Omni-HC), a US based medical communications firm delivering solutions for today’s scientific exchange challenges, is pleased to announce the formation of a strategic alliance with Res Consortium (Res) of the United Kingdom, a cross-sector leader in digital... - August 21, 2021 - Sunny Ayr Holdings
UpSpring® Launches New U.Siip Line of Water Enhancers for Moms
UpSpring LLC, maker of clinically-backed health and wellness solutions for all stages of mom-hood, today announced it has launched U.Siip Water Enhancers with 4 key electrolytes specifically formulated for women who are pregnant or breastfeeding. - August 19, 2021 - Upspring LLC
Food is Medicinal: PRVZN CO Launches LUV Your Mood to Help Make Stress Less Stressful
To help people fight the negative effects of stress, global wellbeing company PRVZN CO LLC, a pioneer in the use of adaptogens, has launched LUV Your Mood. Its selection of ingredients utilizes a powerful blend of Ayurvedic medicine and modern research to create a naturally sound, science-backed supplement for its customers. The dietary supplement features nine adaptogens that support the body's ability to adapt to stress, combat fatigue, and improve mental clarity.* - August 10, 2021 - PRVZN CO LLC
ConSep II™ Filter Module, a Game Changer in Fermentation and High Temperature Cross Flow Filtration Applications
The combination of the patented open channel design and the high temperature capabilities of the ConSep II™ filter module provide unique performance characteristics which customers describe as an "enabling technology" and "a game changer." - July 29, 2021 - SmartFlow Technologies
Malaysia Thailand Collaboration to Increase the Affordability and Accessibility of Cancer Drugs in Thailand Through Local Manufacturing
Strategic collaboration between Malaysia and Thailand has been announced for technology and knowledge transfer to develop R&D and manufacturing of prescription drugs in the initiative to help millions of cancer patients in ASEAN region. - July 28, 2021 - Oncogen Pharma (Malaysia) Sdn Bhd
Microvascular Therapeutics Has Received Funds from the National Heart, Lung and Blood Institute (NHLBI)
Microvascular Therapeutics (MVT) has received funds from the from the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health for its program to treat cardiovascular disease, which kills more Americans than any other disease. As a leader in fluorocarbon... - July 19, 2021 - Microvascular Therapeutics, Inc.
Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase I/II Universal Viral Vaccine Clinical Trial (ALLOPRIME) in Healthy Adults Over 65 Years Old
Mirror Biologics, Inc, (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ vaccines for cancer and infectious diseases where the active... - July 14, 2021 - Mirror Biologics, Inc.
Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase IIB Clinical Trial (STIMVAX) in Patients with Metastatic Colorectal Cancer
Mirror Biologics, Inc. (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ cancer vaccines in which the active ingredients are living... - July 09, 2021 - Mirror Biologics, Inc.
Parvus Therapeutics Announces CEO, Senior Executive, and Board of Directors Appointments
Appoints CEO, Senior Executive, and Board of Directors: Peter M. Strumph, Chief Executive Officer; Brendan Classon PhD, Executive Vice President, Research and Development; Louis Demers, Vice President of Technical Operations; Matthew J. Hogan, member of the Board of Directors - July 06, 2021 - Parvus Therapeutics U.S., Inc.
Defined Bioscience Launches with $1.5M SBIR from the NIH to Advance Stem Cell Media
Defined recently received a $1.5M in Phase II SBIR award from the National Institutes of Health to develop defined media over the next two years. - July 03, 2021 - Defined Bioscience Inc.
Paras Biopharmaceuticals Finland Oy Named as One of the Top Pharma Outsourcing Companies in Europe 2021
Paras Biopharmaceuticals Highlights Company Innovations that Decode and Create Biologics Medicines for Unmet Medical Needs (Pharma Tech Outlook, USA) - June 22, 2021 - Paras Biopharmaceuticals Finland Oy
Targeted Pharmaceuticals and George Mason University Announce First-Ever Preclinical Study Using Cannabinoids in an Organoid Model
Study Examines the Effects of Cannabinoids Treating Central Nervous System (CNS) Viruses including HIV Associated Dementia - June 16, 2021 - Targeted Pharmaceuticals
GENINVO Launches Updated New Website
After months of hard work and dedication, GENINVO is pleased to announce the new and updated website launch. The primary goal of the redesign process was to create a user-focused design, add improved functionality, and provide easy access to information about GENINVO’s products and services. - June 14, 2021 - GenInvo, Inc.
PharmAbbie, Inc. Announces the Launch of a Reg D-506(c) Common Stock Offering
PharmAbbie, Inc. is pleased to announce today that it will offer up to 3,191,489 shares of its Class D Common Stock at an offering price of $4.70 per share for an aggregate offering amount of $15,000,000. The shares will be offered to accredited investors only pursuant to Regulation D, Rule 506(c)... - June 09, 2021 - PharmAbbie, Inc.
Thrivous Launches Omega Cardioprotector Formula 2
Thrivous, the human enhancement company, has released Omega Cardioprotector Formula 2. Omega is an advanced geroprotector supplement that Thrivous develops to enhance heart function and circulation for better aging. Omega formula 2 combines geroprotector nutrients with the highest levels of... - June 03, 2021 - Thrivous
MADSA Joins MAREA
The Malaysian Dietary Supplement Association joins the Malaysian Recycling Alliance to assist Members to play a more meaningful role in ESG and SDG to save the planet. - May 27, 2021 - Malaysian Dietary Supplement Association
Updated Findings of COVID-19 Impact on Biopharmaceutical Industry & CRO Outsourcing Report
2021 Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing and Changes Since 2020 - May 25, 2021 - Life Science Strategy Group, LLC
eCTD Solutions Appoints New CEO and Changes Name to Highlight Expanded Capability
Sunny Ayr Holdings, a group of healthcare product solutions companies, is pleased to announce the change of the name of eCTD Solutions Ltd. to Omni Early Development Services and the appointment of Mark Marino, MD as Partner and Chief Executive Officer of the early product development solutions provider. - May 19, 2021 - Sunny Ayr Holdings
Advanced Silicon Group Closes Seed Preferred Equity Offering and Adds Alan Watson and Sarah Kelly to Board
Advanced Silicon Group, Inc. (ASG), a pioneer in silicon nanotechnology focused on developing novel biosensors, announced today the closing of a $1,020,000 seed preferred stock offering led by Cherrystone Angel Group with participation by MIT Alumni Angels of Northern California, Sidecar Angels and other private investors and the addition of two new Directors, Alan Watson, PhD, MBA and Sarah Kelly, PhD to its Board of Directors. - May 16, 2021 - Advanced Silicon Group
Cayman Develops Powerful, New Multiplex ELISA for Autoantibody Detection
Cayman Chemical's new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases. This... - May 16, 2021 - Cayman Chemical Company
Journal of Longevity Inc. (JOL) Announces the Launch of New Nutritional Supplement Line
Journal of Longevity, Inc. (JOL), a nutritional supplement startup company, is excited to announce the launch of a new health supplement line available now with vitamins and powder supplements for anyone looking to pursue a healthier lifestyle. The launch includes 18 products formulated with... - May 12, 2021 - Journal Of Longevity Inc.
A New Anti-Aging Agent is Making Its Way Into Skincare, and the Results Are on Par with Many Cosmetic Procedures
Topical NAD+ products, previously available by prescription, are exploding onto the aesthetic scene. In 2020, Avior Nutritionals, the makers of Real NAD+, released a nonprescription skincare product that boasts more than twice the amount of NAD+ as its prescription predecessor. Avior’s... - May 07, 2021 - Avior Nutritionals- NADIA Skin
MedShorts Announces Promotion of Blake Powers to President
MedShorts, an Orlando-based e-commerce software solution specializing in connecting pharmacies with pharmaceutical manufacturers to source short-dated and short-supply medications, announced the promotion of Blake Powers to President of the company. After serving as the company’s Chief Operating Officer over the past five years, Blake has advanced to leading the company at a time when hospitals face significant financial pressure to reduce costs within their facilities. - May 06, 2021 - MedShorts LLC
Paras Biopharmaceuticals Finland Oy is Named as One of the Top 30 Admired Companies to Watch 2021
Paras Biopharmaceuticals Finland Oy, a fast-growing, biopharmaceutical technology development company, based in Oulu, Finland, announced today that it is named as one of the top 30 admired companies to watch during 2021, by CIO Bulletin, USA. - April 28, 2021 - Paras Biopharmaceuticals Finland Oy